相似文献
1
Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
AAPS J. 2007 May 11;9(2):E128-47. doi: 10.1208/aapsj0902015.
2
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
3
Nanocarriers for cancer-targeted drug delivery.
J Drug Target. 2016;24(3):179-91. doi: 10.3109/1061186X.2015.1051049. Epub 2015 Jun 10.
4
Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
Biopolymers. 2008;90(5):604-10. doi: 10.1002/bip.20989.
5
Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Curr Drug Metab. 2018;19(2):131-141. doi: 10.2174/1389200218666170728120440.
6
Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Chem Soc Rev. 2013 Sep 7;42(17):7289-325. doi: 10.1039/c3cs60048c. Epub 2013 Apr 3.
7
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
Eur J Pharm Biopharm. 2009 Mar;71(3):431-44. doi: 10.1016/j.ejpb.2008.09.026. Epub 2008 Oct 17.
8
Multifunctional nanocarriers.
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55. doi: 10.1016/j.addr.2006.09.009. Epub 2006 Sep 28.
9
Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Curr Pharm Des. 2017;23(3):481-494. doi: 10.2174/1381612822666161027113654.
10
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):548-58. doi: 10.1016/j.addr.2007.10.008. Epub 2007 Nov 28.
引用本文的文献
1
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis.
ACS Omega. 2025 Jul 19;10(29):31762-31775. doi: 10.1021/acsomega.5c02820. eCollection 2025 Jul 29.
2
Role of nanomedicines in lung cancer treatment and diagnosis: opportunities and challenges.
Med Oncol. 2025 Jun 30;42(8):305. doi: 10.1007/s12032-025-02862-7.
3
Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy.
Clin Pharmacol. 2025 Jun 10;17:119-141. doi: 10.2147/CPAA.S526895. eCollection 2025.
4
[Research advances of liposomes and exosomes in drug delivery and biomarker screening].
Se Pu. 2025 May;43(5):472-486. doi: 10.3724/SP.J.1123.2024.08012.
5
Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective.
Bioimpacts. 2024 May 19;15:30127. doi: 10.34172/bi.30127. eCollection 2025.
6
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
7
Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment.
Int J Nanomedicine. 2025 Jan 4;20:25-52. doi: 10.2147/IJN.S429279. eCollection 2025.
8
Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors.
Asian J Pharm Sci. 2024 Dec;19(6):100980. doi: 10.1016/j.ajps.2024.100980. Epub 2024 Oct 26.
9
Design and development of nanoprobes radiolabelled with Tc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research.
EJNMMI Radiopharm Chem. 2024 Oct 29;9(1):74. doi: 10.1186/s41181-024-00300-z.
10
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review.
Int J Nanomedicine. 2024 Sep 14;19:9503-9547. doi: 10.2147/IJN.S469217. eCollection 2024.
本文引用的文献
1
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.
Adv Drug Deliv Rev. 1995 Sep;16(2-3):215-233. doi: 10.1016/0169-409X(95)00026-4.
2
Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.
J Liposome Res. 2007;17(1):1-14. doi: 10.1080/08982100601186474.
3
Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery.
Mol Biosyst. 2005 Sep;1(3):242-50. doi: 10.1039/b500266d. Epub 2005 Jun 30.
4
"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
Bioconjug Chem. 2006 Jul-Aug;17(4):943-9. doi: 10.1021/bc060080h.
5
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.
Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1196-205. doi: 10.1007/s00259-006-0139-x. Epub 2006 Jun 9.
6
Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods.
J Am Chem Soc. 2006 Feb 15;128(6):2115-20. doi: 10.1021/ja057254a.
7
Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells.
J Biomed Opt. 2005 Nov-Dec;10(6):064035. doi: 10.1117/1.2141825.
8
Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.
Eur J Pharm Biopharm. 2006 Apr;62(3):235-40. doi: 10.1016/j.ejpb.2005.09.010. Epub 2005 Dec 2.
9
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.
J Neurooncol. 2006 May;78(1):7-14. doi: 10.1007/s11060-005-9059-z. Epub 2005 Nov 29.
10
Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
J Drug Target. 2005 Aug;13(7):391-7. doi: 10.1080/10611860500376741.
Zotero 插件